Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Addex Therapeutics
Biotech
Addex stock rises after Indivior offers up to $300M for compound
Indivior is picking up Addex's compound designed to treat substance use disorder, giving the Swiss biotech the chance to make up to $300 million.
Gabrielle Masson
Aug 27, 2024 10:50am
J&J drops Addex epilepsy drug after reviewing phase 2 failure
Jul 18, 2024 5:17am
Addex's Janssen-partnered epilepsy drug fails phase 2 trial
Apr 29, 2024 8:44am
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
Why do so many biotechs face being kicked off the Nasdaq?
Mar 14, 2023 9:55am
Addex scraps Parkinson's phase 3 over COVID-impacted enrollment
Jun 17, 2022 5:50am
